SCHEMBL8423700

SCHEMBL8423700

O=C(O)C1(Oc2ccc(Br)cc2)CCOC(CS(=O)(=O)c2ccccc2)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 1/20 0.37
▸ AOC2 O75106 4/20 0.36
▸ ALDH1A1 P00352 4/20 0.34
▸ MMP1 P03956 4/20 0.34
▸ MMP2 P08253 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ MMP3 P08254 2/20 0.34
▸ MMP9 P14780 2/20 0.34
▸ MMP8 P22894 2/20 0.34
▸ TSHR P16473 2/20 0.34
▸ MMP7 P09237 1/20 0.34
▸ MMP14 P50281 1/20 0.34
▸ ADAM17 P78536 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8425305 0.92 MMP1 (0.37) HSD11B1AOC2ALDH1A1MMP1MMP2
SCHEMBL8428008 0.83 HSD11B1 (0.35) HSD11B1AOC2ALDH1A1MMP1MMP2
SCHEMBL8423694 0.83 PPARG (0.37) HSD11B1AOC2ALDH1A1MMP1MMP2
SCHEMBL8426096 0.80 MMP1 (0.38) HSD11B1ALDH1A1MMP1MMP2KDM4E
SCHEMBL8424027 0.80 ALDH1A1 (0.36) ALDH1A1NPC1HPGDMAPK1RAB9A
SCHEMBL8425466 0.69 DRD4 (0.46) ALDH1A1MMP1MMP2MMP3MMP9
SCHEMBL8423725 0.69 HSD17B10 (0.34) HSD11B1ALDH1A1NPC1HPGDMAPK1
SCHEMBL8424173 0.69 ALDH1A1 (0.36) ALDH1A1ADAM17NPC1HPGDRAB9A
SCHEMBL19110513 0.69 LDHA (0.44) ALDH1A1MAPK1RAB9ALMNAPOLB
SCHEMBL8423697 0.67 MMP2 (0.43) AOC2ALDH1A1MMP1MMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 — — US disclosed
Send feedback